Literature DB >> 7266644

[Preliminary investigation of the in vitro inhibitory effect of antibiotics on algae of the genus Prototheca].

M Casal, J Gutierrez.   

Abstract

We investigated the possible inhibitory action 'in vitro' by antibiotic containing discs against microscopic alga that are potential human pathogens of the genus Prototheca especially P. wickerhamii. The results indicated that inhibitors in vitro included amikacin, colistin, dibecacin, framicetin, gentamycin, kanamycin, lividomycin, neomycin, polymyxin, paromomycin, ribostamycin, sisomycin and tobramycin. We emphasize the interest in the effectiveness at these drugs in a case of human protothecosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7266644     DOI: 10.1007/BF00439066

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  12 in total

1.  A CASE OF HUMAN PROTOTHECOSIS.

Authors:  R R DAVIES; H SPENCER; P O WAKELIN
Journal:  Trans R Soc Trop Med Hyg       Date:  1964-09       Impact factor: 2.184

2.  Cutaneous protothecosis. Successful treatment with amphotericin B.

Authors:  C G Mayhall; C W Miller; A Z Eisen; G S Kobayashi; G Medoff
Journal:  Arch Dermatol       Date:  1976-12

3.  Protothecosis: a case of disseminated algal infection.

Authors:  G E Cox; J D Wilson; P Brown
Journal:  Lancet       Date:  1974-08-17       Impact factor: 79.321

4.  [New findings on the incidence of Alga of the Prototheca species on human skin].

Authors:  C Schönborn; H Pöhler; R Blaschke-Hellmessen
Journal:  Dermatol Monatsschr       Date:  1974-10

5.  [Protothecosis as a new clinical picture].

Authors:  M Casal Román
Journal:  Med Clin (Barc)       Date:  1979-09-15       Impact factor: 1.725

6.  Effects of selected herbicides and plant hormones on Prototheca wickerhamii.

Authors:  P A Henning; R E Lee
Journal:  J Med Microbiol       Date:  1976-02       Impact factor: 2.472

7.  Wound infection by Prototheca wickerhamii, a saprophytic alga pathogenic for man.

Authors:  W S Lee; M D Lagios; R Leonards
Journal:  J Clin Microbiol       Date:  1975-07       Impact factor: 5.948

8.  Cutaneous protothecosis in a patient receiving immunosuppressive therapy.

Authors:  I D Wolfe; H G Sacks; C S Samorodin; H M Robinson
Journal:  Arch Dermatol       Date:  1976-06

9.  Identification of the Prototheca species by immunofluorescence.

Authors:  M S Sudman; W Kaplan
Journal:  Appl Microbiol       Date:  1973-06

10.  Susceptibility of Prototheca species to antifungal agents.

Authors:  E Segal; A A Padhye; L Ajello
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more
  7 in total

1.  Simple new test for presumptive differentiation between genus Candida and genus Prototheca.

Authors:  M Casal; J Gutierrez
Journal:  Mycopathologia       Date:  1986-04       Impact factor: 2.574

2.  First large-scale isolation of Prototheca zopfii from milk produced by dairy herds in Italy.

Authors:  P Buzzini; B Turchetti; R Facelli; R Baudino; F Cavarero; L Mattalia; P Mosso; A Martini
Journal:  Mycopathologia       Date:  2004-11       Impact factor: 2.574

3.  Susceptibility and features of the ultrastructure of Prototheca zopfii following exposure to copper sulphate, silver nitrate and chlorexidine.

Authors:  P A Melville; N R Benites; I L Sinhorini; E O Costa
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

4.  In vitro susceptibility of Prototheca spp. to gentamicin.

Authors:  T A Shahan; R S Pore
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  In vitro activity of ribostamycin against Prototheca sp.

Authors:  M Casal; J Gutierrez Aroca
Journal:  Mycopathologia       Date:  1983       Impact factor: 2.574

6.  First human case of possible protothecosis in Spain.

Authors:  M Casal; J Zerolo; U J Linares; A Ibarra
Journal:  Mycopathologia       Date:  1983       Impact factor: 2.574

Review 7.  Human protothecosis.

Authors:  Cornelia Lass-Flörl; Astrid Mayr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.